COVID-19 Vaccines and the Development of New LUTS

Sponsor
The Hashemite University (Other)
Overall Status
Completed
CT.gov ID
NCT05582525
Collaborator
(none)
341
1
1.9
175.9

Study Details

Study Description

Brief Summary

This study was conducted to check whether coronavirus disease 2019 (COVID) vaccines have a relationship with LUTS or not in a healthy and mostly medically free population.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    341 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Relationship Between the Coronavirus 2019 Disease (COVID-19) Vaccines and the Development of New Lower Urinary Tract Symptoms: A Cross-sectional Study on Medical Students.
    Actual Study Start Date :
    Feb 1, 2022
    Actual Primary Completion Date :
    Apr 1, 2022
    Actual Study Completion Date :
    Apr 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. New Lower Urinary Tract Symptoms [2-3 months]

      Only after having had any COVID -19 vaccine

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Medical Student

    2. Having had a COVID-19 Vaccine

    Exclusion Criteria:

    None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Hashemite University Zarqa Jordan 13133

    Sponsors and Collaborators

    • The Hashemite University

    Investigators

    • Principal Investigator: Jad K AlSmadi, MD, The Hashemite University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jad Khaled AlSmadi, Urology Clinic, The Hashemite University
    ClinicalTrials.gov Identifier:
    NCT05582525
    Other Study ID Numbers:
    • 24/6/2021/2022
    First Posted:
    Oct 17, 2022
    Last Update Posted:
    Oct 17, 2022
    Last Verified:
    Oct 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jad Khaled AlSmadi, Urology Clinic, The Hashemite University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 17, 2022